X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-03 | ISRG | Johnson Amal M | Dir | S - Sale+OE | $238.04 | -6,375 | 11,224 | -36% | -$1,517,487 | |||||
| D | 2022-07-27 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $225.00 | -9,000 | 217 | -98% | -$2,025,000 | |||||
| D | 2022-07-26 | ISRG | Guthart Gary S | Pres, CEO | S - Sale+OE | $216.30 | -79,412 | 1,235,161 | -6% | -$17,177,054 | |||||
| D | 2022-04-26 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $253.04 | -1,611 | 6,355 | -20% | -$407,647 | |||||
| D | 2022-04-26 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $252.51 | -6,000 | 217 | -97% | -$1,515,058 | |||||
| D | 2022-03-01 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $289.96 | -2,000 | 361 | -85% | -$579,920 | |||||
| D | 2022-02-16 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $289.00 | -2,478 | 361 | -87% | -$716,142 | |||||
| D | 2022-01-25 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $263.94 | -6,000 | 285 | -95% | -$1,583,653 | |||||
| D | 2022-01-25 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $261.64 | -1,410 | 1,092 | -56% | -$368,912 | |||||
| D | 2021-11-24 | ISRG | Johnson Amal M | Dir | S - Sale+OE | $333.73 | -7,500 | 10,669 | -41% | -$2,502,954 | |||||
| D | 2021-10-25 | ISR | Mohr Marshall | EVP, CFO | S - Sale+OE | $339.20 | -20,475 | 95,712 | -18% | -$6,945,122 | |||||
| D | 2021-10-22 | ISRG | Samath Jamie | SVP of Finance | S - Sale+OE | $339.66 | -1,503 | 762 | -66% | -$510,510 | |||||
| D | 2021-10-22 | ISRG | Levy Alan J | Dir | S - Sale+OE | $339.64 | -7,500 | 24,282 | -24% | -$2,547,281 | |||||
| D | 2021-10-22 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $339.64 | -6,000 | 285 | -95% | -$2,037,830 | |||||
| D | 2021-10-22 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $339.75 | -1,014 | 1,092 | -48% | -$344,507 | |||||
| D | 2021-09-09 | ISRG | Rubash Mark J | Dir | S - Sale+OE | $1,083.16 | -1,196 | 4,815 | -20% | -$1,295,459 | |||||
| D | 2021-09-09 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $1,082.54 | -4,250 | 95 | -98% | -$4,600,782 | |||||
| D | 2021-08-26 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $1,048.12 | -397 | 364 | -52% | -$416,104 | |||||
| D | 2021-08-11 | ISRG | Johnson Amal M | Dir | S - Sale+OE | $1,001.63 | -2,500 | 3,723 | -40% | -$2,504,087 | |||||
| DM | 2021-08-05 | ISRG | Rosa David J. | EVP, Chief Business Officer | S - Sale+OE | $1,009.56 | -16,211 | 37,501 | -30% | -$16,365,904 | |||||
| D | 2021-08-03 | ISRG | Leonard Keith R | Dir | S - Sale+OE | $1,000.00 | -996 | 849 | -54% | -$996,000 | |||||
| D | 2021-07-26 | ISRG | Mohr Marshall | EVP, CFO | S - Sale+OE | $963.38 | -6,825 | 31,904 | -18% | -$6,575,081 | |||||
| D | 2021-07-23 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $967.26 | -4,004 | 363 | -92% | -$3,872,925 | |||||
| D | 2021-07-23 | ISRG | Samath Jamie | SVP of Finance | S - Sale+OE | $971.64 | -503 | 253 | -67% | -$488,735 | |||||
| D | 2021-07-23 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $967.20 | -1,275 | 7,981 | -14% | -$1,233,179 | |||||
2021-07-23 | ISRG | Ladd Amy L | Dir | S - Sale | $971.64 | -128 | 255 | -33% | -$124,370 | ||||||
| D | 2021-07-23 | ISRG | Levy Alan J | Dir | S - Sale+OE | $967.36 | -2,500 | 8,094 | -24% | -$2,418,408 | |||||
| D | 2021-06-15 | ISRG | Rosa David J. | EVP, Chief Business Officer | S - Sale+OE | $873.23 | -17,038 | 32,712 | -34% | -$14,878,110 | |||||
| D | 2021-05-12 | ISRG | Johnson Amal M | Dir | S - Sale+OE | $817.82 | -2,500 | 3,723 | -40% | -$2,044,557 | |||||
| D | 2021-05-04 | ISRG | Guthart Gary S | Pres, CEO | S - Sale+OE | $851.99 | -10,617 | 393,518 | -3% | -$9,045,591 | |||||
| D | 2021-04-26 | ISRG | Mohr Marshall | EVP, CFO | S - Sale+OE | $865.69 | -21,963 | 31,904 | -41% | -$19,013,222 | |||||
| D | 2021-04-26 | ISRG | Myriam Curet | EVP, Chief Medical Officer | S - Sale+OE | $866.44 | -875 | 124 | -88% | -$758,135 | |||||
| D | 2021-04-23 | ISRG | Samath Jamie | SVP of Finance | S - Sale+OE | $848.58 | -793 | 253 | -76% | -$672,924 | |||||
| D | 2021-04-23 | ISRG | Levy Alan J | Dir | S - Sale+OE | $856.79 | -2,500 | 8,094 | -24% | -$2,141,970 | |||||
| D | 2021-04-23 | ISRG | Andersen Reiter Kara | SVP GC, CCO | S - Sale+OE | $848.01 | -750 | 4,844 | -13% | -$636,008 | |||||
| D | 2021-04-23 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $860.26 | -5,100 | 7,981 | -39% | -$4,387,334 | |||||
| D | 2021-03-02 | ISRG | Myriam Curet | EVP, Chief Medical Officer | S - Sale+OE | $760.00 | -379 | 124 | -75% | -$288,040 | |||||
| D | 2021-03-02 | ISRG | Samath Jamie | SVP of Finance | S - Sale+OE | $760.00 | -215 | 253 | -46% | -$163,400 | |||||
| D | 2021-02-17 | ISRG | Desantis Robert | EVP, GM IA, E | S - Sale+OE | $782.00 | -2,958 | 2,539 | -54% | -$2,313,156 | |||||
| DM | 2019-02-19 | ISRG | Myriam Curet | EVP, Chief Medical Officer | S - Sale+OE | $623.58 | -4,423 | 124 | -97% | -$2,758,114 | |||||
| D | 2021-02-17 | ISRG | Samath Jamie | SVP of Finance | S - Sale+OE | $782.00 | -655 | 253 | -72% | -$512,210 | |||||
| D | 2021-02-11 | ISRG | Mohr Marshall | EVP, CFO | S - Sale+OE | $800.00 | -12,487 | 21,834 | -36% | -$9,989,602 | |||||
| D | 2021-02-02 | ISRG | Guthart Gary S | Pres, CEO | S - Sale+OE | $762.14 | -11,020 | 387,134 | -3% | -$8,398,759 | |||||
| D | 2021-01-29 | ISRG | Mohr Marshall | EVP, CFO | S - Sale+OE | $751.67 | -9,375 | 13,321 | -41% | -$7,046,858 | |||||
| D | 2021-01-26 | ISRG | Samath Jamie | SVP of Finance | S - Sale+OE | $754.48 | -521 | 207 | -72% | -$393,084 | |||||
| D | 2021-01-26 | ISRG | Andersen Reiter Kara | SVP GC, CCO | S - Sale+OE | $754.48 | -1,652 | 3,666 | -31% | -$1,246,401 | |||||
| D | 2021-01-26 | ISRG | Levy Alan J | Dir | S - Sale+OE | $754.48 | -2,500 | 7,839 | -24% | -$1,886,200 | |||||
| DM | 2020-12-08 | ISRG | Guthart Gary S | Pres, CEO | S - Sale+OE | $760.60 | -16,914 | 384,154 | -4% | -$12,864,811 | |||||
| D | 2020-12-07 | ISRG | Samath Jamie | SVP of Finance | S - Sale+OE | $778.00 | -407 | 207 | -66% | -$316,646 | |||||
| D | 2020-10-26 | ISRG | Mohr Marshall | EVP, CFO | S - Sale+OE | $715.28 | -6,000 | 15,399 | -28% | -$4,291,690 | |||||
| D | 2020-10-20 | ISRG | Myriam Curet | EVP, Chief Medical Officer | S - Sale+OE | $736.12 | -875 | 2,986 | -23% | -$644,105 | |||||
| D | 2020-10-20 | ISRG | Andersen Reiter Kara | SVP GC, CCO | S - Sale+OE | $736.12 | -1,250 | 4,068 | -24% | -$920,150 | |||||
| D | 2020-10-20 | ISRG | Samath Jamie | SVP of Finance | S - Sale+OE | $736.12 | -754 | 207 | -78% | -$555,034 | |||||
| D | 2020-10-20 | ISRG | Levy Alan J | Dir | S - Sale+OE | $736.12 | -1,800 | 7,839 | -19% | -$1,325,016 | |||||
| D | 2020-09-10 | ISRG | Andersen Reiter Kara | SVP GC, CCO | S - Sale+OE | $718.50 | -1,514 | 4,068 | -27% | -$1,087,809 | |||||
| D | 2020-08-31 | ISRG | Rubash Mark J | Dir | S - Sale+OE | $723.73 | -1,000 | 4,560 | -18% | -$723,730 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |